Quality Assurance and Legal Issues in Healthcare

Demonstrate basic knowledge of terminology for national organizations, agencies, regulations that support quality assurance in healthcare.
Define quality and performance improvement measurements as they relate to phlebotomy.
Describe components of a quality assurance (QA) program.
Identify areas in phlebotomy subject to quality control (QC).
Demonstrate knowledge of legal aspects associated with phlebotomy procedures, including legal terminology and situational implications.
Understand confidentiality and regulations for handling personal information, such as HIPAA.

Definition of Quality: The degree of excellence of something.
Quality Assurance (QA): Involves all activities and programs to guarantee excellence in patient care. It is a continuous process that aims to identify quality problems and establish standards to address them.
Quality Assessment: Data collection and analysis to determine if QA standards are being met.
Continuous Quality Improvement (CQI): A system for continuous monitoring and improvement of quality by analyzing processes and identifying areas needing improvement.

Joint Commission (TJC):
- Oldest and largest standard-setting body in U.S. healthcare.
- Nonprofit organization establishing standards for hospitals and healthcare facilities, accrediting and certifying them.
- Gold Seal of Approval received upon passing a survey, which occurs every three years (two years for labs).
- Focus on quality care and patient safety, reducing analytical errors in pre-analytical and post-analytical processes.
- Pre-analytical Errors: Can include patient misidentification; critical for the phlebotomist.

Significance of Accurate Patient Identification:
- Errors due to mislabeling can lead to misdiagnosis and treatment of wrong patients, resulting in severe consequences.
Post-analytical Processes: Involve actions following testing that must be monitored for QA and compliance.
Point of Care Testing:
- Example: Glucose bedside testing, which requires monitoring for quality and proper procedures.

SAFER (Survey Analysis for Evaluating Risk):
- A method used by The Joint Commission to evaluate risk and deficiencies during surveys.
- Provides a matrix illustrating the likelihood of harm from noncompliance.
- Risk levels are rated as low, moderate, or high, with a 60-day timeline for demonstrating compliance.

Healthcare facilities must prioritize accountability to the patient, and departments need to align with patients' expectations and compliance.
Complaints submitted may prompt the Joint Commission to conduct unannounced assessments for compliance.
Sentinel Events: Unfavorable events leading to death or serious injury that require immediate investigation and corrective action.

2023 NPSGs for Clinical Labs focus on:
1. Patient Identification: Utilize at least two identifiers (e.g., name and date of birth). Room numbers should not be used as they can lead to confusion due to patient transfers.
2. Specimen Labeling: Label blood and other specimens in the presence of the patient immediately after collection.
3. Effective Staff Communication: Ensure test results are delivered promptly to the appropriate staff.
4. Infection Prevention: Adopt hand cleaning guidelines to reduce healthcare-associated infections.

Overview: Federal regulations established in 1988 designed to ensure quality standards in labs that test human specimens.
Key Components of CLIA:
- Focus on QA, QC, proficiency testing, laboratory records, and personnel qualifications.
- Labs are categorized into three levels of complexity: Waived, Moderate, and High complexity.
- Waived Tests: Simple tests with minimal error risk, such as home pregnancy tests.

Guidelines outlined by CLIAC for waived testing labs emphasize quality assurance, including:
1. Maintain updated product inserts and follow the manufacturer’s instructions.
2. Ensure proper patient and specimen identification.
3. Inform patients of required test preparations.
4. Store test kits according to guidelines and do not mix components from different kits.

College of American Pathologists (CAP):
- Influences quality care through standards specifically for pathology labs.
- Requires labs to have competency assessments for staff.
Clinical and Laboratory Standards Institute (CLSI):
- Develops voluntary guidelines and standards for all laboratory areas, ensuring quality and care in phlebotomy.
National Accrediting Agency for Clinical Laboratory Sciences (NAACLS):
- Oversees educational standards in clinical laboratory education to enhance student outcomes.
International Organization for Standardization (ISO):
- Develops global quality standards for safety and reliability in products and services.

Phlebotomists play a critical role in healthcare as test results directly affect patient treatment.
Maintaining high standards in specimen collection and handling is crucial for achieving accurate test results.

Hospitals must implement quality assurance programs to review processes and identify errors, leading to process improvement techniques (PI).
Tools for Improving Quality:
- FMEA (Failure Modes and Effects Analysis): Evaluates potential errors and outcomes from failures.
- Lean Methodology: Focuses on eliminating waste and enhancing processes.
- Six Sigma: Strives to minimize waste in both pre-analytical and post-analytical processes.
- Root Cause Analysis (RCA): Investigative approach for identifying causes of problems that have occurred.

Quality Indicators: Measurements that provide insight into the processes and outcomes of lab practices.
Thresholds: Levels beyond which quality patient care must be evaluated for compliance and improvement.
Corrective Action Preventative Action (CAPA): A process initiated when a problem is detected, aiming for corrective measures and effectiveness checks to ensure issues do not reoccur.

Effective quality assurance encompasses understanding and applying various regulatory standards, maintaining communication, and continuous improvement to foster a safe environment for patient care.